Suchergebnisse

Konferenzbeitrag (7)

  1. 221.
    Konferenzbeitrag
    Levin, J.; Wagner, J.; Ryazanov, S.; Leonov, A.; Shi, S.; Schmidt, F.; Prix, C.; Bertsch, U.; Mitteregger-Kretzschmar, G.; Geissen, M. et al.; Hischberger, T.; Tavan, P.; Pilger, J.; Zweckstetter, M.; Frank, T.; Baehr, M.; Weishaupt, J.; Uhr, M.; Urlaub, H.; Teichmann, U.; Boetzel, K.; Groschup, M.; Kretzschmar, H. A.; Griesinger, C.; Giese, A.: Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor. 15th International Congress of Parkinsons Disease and Movement Disorders, Toronto, CANADA, 2011. Movement Disorders 26 (Supplement 2), S. S21 - S21 (2011)
  2. 222.
    Konferenzbeitrag
    Montaville, P.; Kim, H. Y.; Vijayan, V.; Becker, S.; Zweckstetter, M.: H-1, N-15, and C-13 resonance assignment of the C2A domain of rabphilin3A. Journal of Biomolecular NMR 36 (Suppl. 1), S. 20 - 20 (2006)
  3. 223.
    Konferenzbeitrag
    Bertoncini, C. W.; Cherny, D. I.; Fernandez, C. O.; Garfinkel, E.; Griesinger, C.; Hoyer, W.; Jares-Erijman, E. A.; Jovin, T. M.; Marsh, D.; Rasia, R. M. et al.; Roberti, M. J.; Subramaniam, V.; Zweckstetter, M.: 3D structure, ligand binding, autoinhibition, aggregation, and cellular distribution of wild-type, mutant, and labeled alpha-synuclein. Biophysical Journal 88 (1), S. 396A - 396A (2005)

Meeting Abstract (1)

  1. 224.
    Meeting Abstract
    Villinger, S.; Briones, R.; Giller, K.; Zachariae, U.; Lange, A.; de Groot, B. L.; Griesinger, C.; Becker, S.; Zweckstetter, M.: Functional dynamics in the voltage-dependent anion channel. In FEBS Journal, 279 (Suppl. 1), P20-86, S. 433 - 433. 22nd IUBMB Congress/37th FEBS Congress, Seville/Spain, 04. September 2012 - 09. September 2012. (2012)

Patent (1)

  1. 225.
    Patent
    Zweckstetter, M.; Karpinar, P.; Griesinger, C.: Mutant alpha-synuclein with increased toxicity. WO/2010/015714 (2010)
Zur Redakteursansicht